Like many other things, biomedical re-search is moving east. A paper published in the New England Journal of Medicine by a team led by Justin Chakma of Thomas, McNerney & Partners, an American venture-capital firm, shows a marked shift in spending from Europe and North America to Asia. In China, where the most recent five-year plan has made such research a priority, the amount disbursed increased, in real terms, by an average of 33% a year between 2007 and 2012. In Japan it was up by an average of 6% each year. In the United States it fell by 2% a year. As a consequence, America's share of the total shrank from 51% in 2007 to 45% in 2012.
展开▼
